Pfizer's plans for Lipitor post-patent - reinforces what Dew has been saying about this still being a viable worldwide franchise: http://blogs.wsj.com/health/2011/11/22/a-m-vitals-pfizer-plans-to-sell-lipitor-at-generic-prices-directly-to-patients/